Back

TAVI is preferred to surgery for low-risk patients - PRO.

1 September 2020 (10:28 - 10:37)
Organised by:
Congress Presentation Part of: Controversies in Aortic Stenosis: Is TAVI the Preferred Therapy for Low-Risk Patients? Treatment ESC Premium Access ESC Congress 2020

About the speaker

Photo
Professor Giuseppe Tarantini

University of Padua, Padova (Italy)

2 More presentations in this session

Presentation thumbnail
TAVI is preferred to surgery for low-risk patients - CON.
Professor V. Falk (Berlin, DE)
Slides Video
Presentation thumbnail
TAVI is preferred to surgery for low-risk patients - Discussion.

Access the full session

Session thumbnail
Controversies in Aortic Stenosis: Is TAVI the Preferred Therapy for Low-Risk Patients?
Video

The Event

Event poster

ESC Congress 2020

1 September 2020 10:28 CET
You may be interested in
thumbnail
Congress Presentation
Three-year outcomes following transcatheter versus surgical aortic valve replacement in younger, low surgical risk patients with severe aortic stenosis
26 August 2023
thumbnail
Congress Presentation
Cardiovascular risk and coronary artery disease burden in TAVI patients
29 June 2021
thumbnail
Congress Presentation
Contemporary trends and outcomes of percutaneous vs. surgical aortic valve replacement in cancer patients.
1 September 2019
thumbnail
Congress Presentation
TAVI via alternative access routes: patient selection and 10-year center experience
1 July 2021

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources